Waters Corporation at MSACL 2026

3 - 8. October 2026
Join Waters at MSACL 2026 to explore clinical LC-MS/MS innovations, Xevo TQ Absolute XR IVD, diagnostic workflows, expert sessions, workshops, and scientific posters.
Waters Corporation at MSACL 2026

Advancing Diagnostics Through Innovative Technologies.

Join Waters at the MSACL 2026, hosted by The Association for Mass Spectrometry & Advances in the Clinical Lab, as we showcase how our innovations in clinical diagnostics can help laboratories improve efficiency, enhance diagnostic confidence, and advance patient care.

Experience Our Innovation Showcase

  • Discover the new Xevo™ TQ Absolute XR IVD Mass Spectrometer along with other innovations including the MassTrak™ Immunosuppresants Kit IVD with FDA 510(k)-cleared LC-MS/MS assay for tacrolimus quantification to support transplant patient care
  • Explore Waters Academy-Clinical, a training platform that provides onboarding, training, and ongoing education for your laboratory staff using Waters LC-MS/MS systems
  • Expert insights from Waters scientists and product specialists 

Waters Petite Suite Sessions

Talk Title: Maximizing Column Lifetime Through Improved Contamination Management
  • Wednesday, October 7 | 11:30am-12:45pm
  • Thursday, October 8 | 7:45am-8:45am
  • Outremont 4
  • Guy Boisvert (Clinical & Forensics Chemistry Account Manager, Waters Advanced Diagnostics)
Talk Title: Robust by Design: Mastering Method Robustness with Smart Pre-MS1 Filtering and Chromatographic Strategies
  • Wednesday, October 7 | 5:00pm-6:30pm
  • Thursday, October 8 | 12:15pm-1:15pm
  • Outremont 4
  • David Farrell (Senior Scientist, Waters Advanced Diagnostics)
  • Dominic Foley (Consulting Scientist, Waters Advanced Diagnostics)

Waters Industry Breakfast Workshop: Expanding the Boundaries of LC-MS/MS

Talk Title: Doctor, Did You Get it All? Mass Spectrometry in the Operating Room; Adding a New Dimension to the Surgeon's Field of Vision
  • John Rudan, MD FRCCPS (Kingston General Hospital)
Talk Title: Mass Spectrometry Strategies for Translational Research: From Biomarker Discovery to Clinical Applications
  • Christiane Auray-Blais, LL.M., Ph.D. (Université de Sherbrooke)

Scientific Posters

Visit our poster presentations to learn more about the latest advancements in LC-MS/MS applications.

  • P-63 - Wednesday, October 7 9:15am EDT - Enhanced Ultra Sensitive Measurement of Serum Estrogens Using the Xevo TQ Absolute XR with UHPLC MS/MS for Clinical Research Applications
    • Dominic Foley
  • P-79 - Wednesday, October 7 - 9:15am EDT - LC‑MS/MS Measurement of Infliximab, Adalimumab, Ustekinumab, Vedolizumab and Anti‑Drug Antibodies Using mAbXmise Kits on the Xevo TQ Absolute XR MS for Clinical Research
    • Frank Kero
  • P-85 - Wednesday, October 7 9:15am EDT - Troubleshooting an Intact Peptide IP-LC-MS/MS Clinical Research Method for Amyloid-βeta Quantification in Human Plasma. A Sticky Issue!
    • John Vukovic
  • P-63 - Thursday, October 8 10:00am EDT - Long Run LC–MS/MS Robustness in Plasma: a 30,000-Injection Evaluation of Quantitative Stability, Carryover, and Uptime on a Triple Quadrupole System for Clinical Research
    • David Farrell

We Look Forward to Seeing You at MSACL 2026

Join us at Booth #21 as we celebrate the next chapter of LC-MS/MS diagnostic innovation and demonstrate how Waters is helping laboratories transform diagnostic workflows, improve efficiency, and advance patient care.

Waters Corporation
LinkedIn Logo